nafamostat has been researched along with ono 3307 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pilgram, O; Steinmetzer, T; Wenzel, BM; Wiedemeyer, SJA | 1 |
| Futagami, M; Imaki, K; Kawasaki, A; Matsuoka, S; Ohno, H; Okegawa, T | 1 |
2 other study(ies) available for nafamostat and ono 3307
| Article | Year |
|---|---|
Fibrinolysis Inhibitors: Potential Drugs for the Treatment and Prevention of Bleeding.
Topics: Animals; Antifibrinolytic Agents; Catalytic Domain; Crystallography, X-Ray; Fibrinolysin; Fibrinolysis; Hemorrhage; Humans; Ligands; Molecular Structure; Plasminogen; Protein Binding; Protein Domains | 2020 |
Inhibitory effects of ONO-3307 on various proteases and tissue thromboplastin in vitro and on experimental thrombosis in vivo.
Topics: Animals; Benzamidines; Dialysis; Endotoxins; Fibrinolytic Agents; Gabexate; Guanidines; Humans; In Vitro Techniques; Indicators and Reagents; Kinetics; Leukocytes; Male; N-Formylmethionine Leucyl-Phenylalanine; Pancreatic Elastase; Rats; Rats, Inbred Strains; Serine Proteinase Inhibitors; Thromboplastin | 1989 |